BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35470290)

  • 1. Treatment of Orbital Desmoid-type Fibromatosis With Sorafenib.
    Downie EM; Amend CE; Miranda A; Burkat CN
    Ophthalmic Plast Reconstr Surg; 2022 Sep-Oct 01; 38(5):e144-e147. PubMed ID: 35470290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging Role of Multikinase Inhibitors in Desmoid Tumor Management.
    Penel N; Ryckewaert T; Le Deley MC
    Am J Clin Oncol; 2019 Dec; 42(12):958. PubMed ID: 31764064
    [No Abstract]   [Full Text] [Related]  

  • 3. Activity of Sorafenib against desmoid tumor/deep fibromatosis.
    Gounder MM; Lefkowitz RA; Keohan ML; D'Adamo DR; Hameed M; Antonescu CR; Singer S; Stout K; Ahn L; Maki RG
    Clin Cancer Res; 2011 Jun; 17(12):4082-90. PubMed ID: 21447727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy with sorafenib and celecoxib for pediatric patients with desmoid tumor.
    Robles J; Keskinyan VS; Thompson M; Davis JT; Mater DV
    Pediatr Hematol Oncol; 2020 Aug; 37(5):445-449. PubMed ID: 32129687
    [No Abstract]   [Full Text] [Related]  

  • 5. Medical treatment of mammary desmoid-type fibromatosis: which benefit?
    Scheer L; Lodi M; Molière S; Kurtz JE; Mathelin C
    World J Surg Oncol; 2017 Apr; 15(1):86. PubMed ID: 28420393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extra-abdominal aggressive fibromatosis treated with meloxicam and sorafenib: An encouraging option.
    Sari M
    J Cancer Res Ther; 2020; 16(4):900-902. PubMed ID: 32930137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desmoid tumours stalled by sorafenib.
    Wrighton KH
    Nat Rev Clin Oncol; 2019 Apr; 16(4):209. PubMed ID: 30664677
    [No Abstract]   [Full Text] [Related]  

  • 8. Desmoid-type fibromatosis of the breast: A case report.
    Bhat D; Wear V; Weisenberg E; Alvarado R
    Breast Dis; 2016; 36(4):149-152. PubMed ID: 27612042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desmoid-type fibromatosis: toward a holistic management.
    Penel N; Kasper B; van Der Graaf WTA
    Curr Opin Oncol; 2021 Jul; 33(4):309-314. PubMed ID: 33973549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of sorafenib in desmoid-type fibromatosis: A need to review dose.
    Garg V; Gangadharaiah BB; Rastogi S; Upadhyay A; Barwad A; Dhamija E; Gamangatti S
    Eur J Cancer; 2023 Jun; 186():142-150. PubMed ID: 37062211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An unusual finding in a desmoid-type fibromatosis of the pancreas: a case report and review of the literature.
    Torres JC; Xin C
    J Med Case Rep; 2018 May; 12(1):123. PubMed ID: 29751773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rare sporadic pancreatic desmoid fibromatosis diagnosed by endoscopic ultrasound-guided fine-needle aspiration: Case report and literature review.
    Stone AB; Mallery JS; Stewart J; Amin K
    Diagn Cytopathol; 2021 Feb; 49(2):E49-E54. PubMed ID: 32857922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-word experience of pazopanib and sorafenib in patients with desmoid tumors: A CanSaRCC multi-center study.
    Noujaim J; Gupta AA; Holloway CL; Saleh R; Srikanthan A; Lemieux C; Soroka HP; Tibout P; Turcotte R; Feng X; Abdul Razak AR; Costa P
    Eur J Cancer; 2024 Jul; 205():114119. PubMed ID: 38759389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desmoid Fibromatosis: Management in an Era of Increasing Options.
    Ratan R; Roland CL; Bishop AJ
    Curr Oncol Rep; 2021 Mar; 23(4):41. PubMed ID: 33719012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current management and recent progress in desmoid tumors.
    Zhou MY; Bui NQ; Charville GW; Ghanouni P; Ganjoo KN
    Cancer Treat Res Commun; 2022; 31():100562. PubMed ID: 35460976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Evolving Management of Desmoid Fibromatosis.
    Prendergast K; Kryeziu S; Crago AM
    Surg Clin North Am; 2022 Aug; 102(4):667-677. PubMed ID: 35952695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Desmoid-type fibromatosis difficult to distinguish from GIST : A case report.
    Takehara Y; Yoshikawa K; Tokunaga T; Nishi M; Takasu C; Kashihara H; Yoshimoto T; Shimada M
    J Med Invest; 2020; 67(3.4):375-377. PubMed ID: 33148921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desmoid-type fibromatosis mimicking uterine fibroid invade the urinary bladder: A case report and literature review.
    Hung YT; Huang YF; Wu PY
    Taiwan J Obstet Gynecol; 2023 Jan; 62(1):158-162. PubMed ID: 36720531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric desmoid fibromatosis of the parapharyngeal space: A case report and review of literature.
    Zheng Z; Jordan AC; Hackett AM; Chai RL
    Am J Otolaryngol; 2016; 37(4):372-5. PubMed ID: 27040413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In desmoid-type fibromatosis cells sorafenib induces ferroptosis and apoptosis, which are enhanced by autophagy inhibition.
    Schut AW; Vriends ALM; Sacchetti A; Timbergen MJM; Alman BA; Al-Jazrawe M; Grünhagen DJ; Verhoef C; Sleijfer S; Wiemer EAC
    Eur J Surg Oncol; 2022 Jul; 48(7):1527-1535. PubMed ID: 35221159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.